Cáncer de pulmón no microcítico (células no pequeñas)

+ -Text Size

Otros recursos y referencias TEMAS

Referencias: guía detallada del cáncer de pulmón no microcítico

Alberg AJ, Brock MV, Stuart JM. Epidemiology of lung cancer: Looking to the future. J Clin Oncol. 2005;23:3175–3185.

American Cancer Society. Cancer Facts & Figures 2014. Atlanta, Ga: American Cancer Society; 2014.

American Cancer Society. Cancer Facts & Figures for African Americans 2013-2014. Atlanta, Ga: American Cancer Society; 2013.

American Joint Committee on Cancer. Lung. AJCC Cancer Staging Manual. 7th ed. New York: Springer. 2010:253–266.

Amos CI, Pinney SM, Li Y, et al. A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res. 2010;70:2359–2367.

Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines. Chest. 2007:69S–77.

Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455–2465.

Butts C, Maksymiuk A, Goss G, et al. Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. J Cancer Res Clin Oncol. 2011;137:1337–1342.

Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase 3 study. Lancet. 2009;374:1432−1440.

Cohen AJ, Ross Anderson H, Ostro B, et al. The global burden of disease due to outdoor air pollution. J Toxicol Environ Health A. 2005;68:1301–1307.

Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: Validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:694–705.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012.

Johnson DH, Blot WJ, Carbone DP, et al. Cancer of the lung: non-small cell lung cancer and small cell lung cancer. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1307–1366.

Kaufman EL, Jacobson JS, Hershman DL, et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26:392–398.

Kwak EL, Bang Y, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small cell lung cancer. New Engl J Med. 2010;363:1693–1703.

National Cancer Institute. Physician Data Query (PDQ). Non-Small Cell Lung Cancer Treatment. 2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/healthprofessional on March 18, 2013.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. V.2.2013. Accessed at www.nccn.org/professionals/physician_gls/PDF/nscl.pdf on March 18, 2013.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol. 2000;18:2406–2412.

Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.

Posther KE, Harpole DH. The surgical management of lung cancer. Cancer Investigation. 2006;24:56–67.

Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307:173–181.

Quoix E, Ramlau R, Westeel V, et al. Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: A controlled phase 2B trial. Lancet Oncol. 2011;12:1125–1133.

Schrump DS, Carter D, Kelsey CR, Marks LB, Giaccone G. Non-small cell lung cancer. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:799–847.

Sequist LV, Yang JC, Yamamoto N, et al. Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations. J Clin Oncol. 2013 Jul 1. [Epub ahead of print]

US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Washington, DC: Department of Health and Human Services; 2006. Accessed at www.surgeongeneral.gov/library/reports/secondhandsmoke/index.html on March 18, 2013.

US Preventive Services Task Force. Lung cancer screening. Ann Int Med. 2004;140:738–739.

Schottenfeld D. The etiology and epidemiology of lung cancer. In: Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi AT, eds. Principles and Practice of Lung Cancer. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins. 2010:3–22.

Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–2454.

Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–285.

Wender R, Fontham E, Barrera E, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63:106–117.

Wozniak AJ, Gadgeel SM. Clinical presentation of non-small cell carcinoma of the lung. In: Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi AT, eds. Principles and Practice of Lung Cancer. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins. 2010:327–340.

Zhou W, Heist RS, Liu G, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007;25:479–485.


Fecha de última actualización: 07/15/2013
Fecha de último cambio o revisión: 02/12/2014